PSK-1404

N/A

Report date: 2022/07/19 14:43:53
NME

Base Information

Drug NamePSK-1404
Drug Alias NamePSK-1404
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-V/beta-3 antagonists
TargetsIntegrin alpha-V/beta-3
Therapy Area/IndicationsBone Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKyowa Hakko Kirin Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKyowa Hakko Kirin Co Ltd
Active IndicationsN/A
Inactive IndicationsBone Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A